首页> 外国专利> anti-trka antibody, antibody or derivative, antibody derivative, combination of antibody or derivative, pharmaceutical composition, method, polypeptide, nucleic acid encoding an antibody or derivative thereof, vector, expression system, non-human transgenic mammal and kit I understand an antibody or derivative

anti-trka antibody, antibody or derivative, antibody derivative, combination of antibody or derivative, pharmaceutical composition, method, polypeptide, nucleic acid encoding an antibody or derivative thereof, vector, expression system, non-human transgenic mammal and kit I understand an antibody or derivative

机译:抗trka抗体,抗体或衍生物,抗体衍生物,抗体或衍生物的组合,药物组合物,方法,多肽,编码抗体或其衍生物的核酸,载体,表达系统,非人类转基因哺乳动物和试剂盒我了解抗体或衍生

摘要

An anti-TrkA antibody is provided that comprises: a) a variable heavy chain comprising a sequence selected from any of BXhVH1, BXhVH2, BXhVH3, BXhVH4, BXhVH5, or HuVHWOv as shown in FIG. 1a; or from variants of any of said sequences and/or b) a variable light chain comprising a sequence selected from any of BXhVL1, BXhVL2, BXhVL3, BXhVL4, BXhVL5, BXhVL6, BXhVL7 or BXhVL8; as shown in FIG. 1b, or from variants of any of said sequences. TrkA-binding derivatives are also provided. Antibodies or derivatives of the present invention are useful in a number of therapies, including pain therapy.
机译:提供了一种抗-TrkA抗体,其包含:a)可变重链,其包含选自BXhVH1,BXhVH2,BXhVH3,BXhVH4,BXhVH5或HuVHWOv中的任一个的序列。 1a;或来自任何所述序列的变体和/或b)包含选自以下的序列的可变轻链:BXhVL1,BXhVL2,BXhVL3,BXhVL4,BXhVL5,BXhVL6,BXhVL7或BXhVL8。如图1b,或来自任何所述序列的变体。还提供了TrkA结合衍生物。本发明的抗体或衍生物可用于许多疗法,包括疼痛疗法。

著录项

  • 公开/公告号BRPI0905955A8

    专利类型

  • 公开/公告日2018-05-08

    原文格式PDF

  • 申请/专利权人 LAY LINE GENOMICS S.P.A.;

    申请/专利号BR2009PI05955

  • 发明设计人 DANIELE D AMBROSIO;FABIO BENIGNI;

    申请日2009-02-04

  • 分类号C10L5/44;

  • 国家 BR

  • 入库时间 2022-08-21 12:53:17

相似文献

  • 专利
  • 外文文献
  • 中文文献
获取专利

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号